Emelia J Benjamin Selected Research

Fibrosis (Cirrhosis)

1/2021	Hepatic Fibrosis Associates With Multiple Cardiometabolic Disease Risk Factors: The Framingham Heart Study.
1/2020	Relations between plasma microRNAs, echocardiographic markers of atrial remodeling, and atrial fibrillation: Data from the Framingham Offspring study.
5/2014	Galectin 3 and incident atrial fibrillation in the community.
5/2004	Relations of serum aldosterone to cardiac structure: gender-related differences in the Framingham Heart Study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Emelia J Benjamin Research Topics

Disease

60	Cardiovascular Diseases (Cardiovascular Disease) 05/2024 - 03/2003
57	Atrial Fibrillation 11/2023 - 02/2004
56	Inflammation (Inflammations) 12/2024 - 07/2004
47	Heart Failure 05/2024 - 08/2002
46	Hypertension (High Blood Pressure) 01/2021 - 03/2003
27	Stroke (Strokes) 04/2024 - 08/2003
26	Myocardial Infarction 11/2022 - 01/2003
22	Diabetes Mellitus 01/2020 - 12/2004
15	Atherosclerosis 12/2023 - 08/2005
15	Obesity 10/2022 - 03/2003
12	Coronary Disease (Coronary Heart Disease) 01/2021 - 02/2004
10	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2021 - 01/2007
8	Insulin Resistance 05/2017 - 01/2003
7	Neoplasms (Cancer) 01/2023 - 01/2007
6	Dementia (Dementias) 01/2023 - 12/2010
6	Chronic Renal Insufficiency 01/2016 - 06/2008
5	Hyperemia 10/2018 - 12/2004
5	Thrombosis (Thrombus) 01/2017 - 03/2007
5	Apnea 01/2016 - 10/2006
5	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 11/2013 - 09/2002
5	Ventricular Remodeling 09/2012 - 03/2003
4	Sepsis (Septicemia) 11/2021 - 06/2013
4	Albuminuria 09/2021 - 03/2007
4	Fibrosis (Cirrhosis) 01/2021 - 05/2004
4	Ischemic Stroke 01/2017 - 08/2003
4	Type 2 Diabetes Mellitus (MODY) 01/2017 - 02/2006
4	Hypertrophy 11/2013 - 09/2004
3	Cognitive Dysfunction 10/2022 - 01/2017
3	Long QT Syndrome 01/2022 - 03/2005
3	Cardiac Arrhythmias (Arrythmia) 12/2021 - 06/2014
3	Heart Diseases (Heart Disease) 01/2021 - 08/2007
3	Heart Valve Diseases (Valvular Heart Disease) 01/2020 - 03/2009
3	Atrial Remodeling 01/2020 - 02/2009
3	Coronary Artery Disease (Coronary Atherosclerosis) 09/2017 - 10/2004
3	Alzheimer Disease (Alzheimer's Disease) 01/2017 - 11/2011
3	Infections 04/2015 - 03/2014
3	Necrosis 07/2013 - 06/2008

Drug/Important Bio-Agent (IBA)

71	Biomarkers (Surrogate Marker)IBA 12/2024 - 10/2005
47	C-Reactive ProteinIBA 12/2024 - 03/2003
26	Antihypertensive Agents (Antihypertensives)IBA 11/2022 - 04/2003
23	HDL CholesterolIBA 01/2021 - 03/2003
23	Interleukin-6 (Interleukin 6)IBA 01/2017 - 03/2003
16	Glucose (Dextrose)FDA LinkGeneric 01/2024 - 01/2003
15	Brain Natriuretic Peptide (Natrecor)FDA Link 05/2024 - 09/2002
15	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2021 - 12/2004
14	Fibrinogen (Factor I)FDA Link 01/2018 - 03/2007
13	CreatinineIBA 09/2021 - 03/2003
13	CholesterolIBA 01/2021 - 12/2004
13	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 02/2015 - 07/2004
12	Natriuretic PeptidesIBA 01/2018 - 08/2002
12	LipidsIBA 01/2017 - 11/2006
11	AldosteroneIBA 01/2010 - 05/2004
10	AlbuminsIBA 09/2021 - 02/2006
10	P-SelectinIBA 01/2018 - 04/2006
9	OsteoprotegerinIBA 02/2016 - 06/2008
9	ReninIBA 01/2010 - 02/2006
8	Proteins (Proteins, Gene)FDA Link 01/2023 - 06/2006
8	HomocysteineIBA 01/2017 - 03/2004
7	AdipokinesIBA 10/2022 - 03/2009
7	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2017 - 03/2003
6	Type II Tumor Necrosis Factor ReceptorsIBA 10/2022 - 03/2011
6	Plasminogen Activator Inhibitor 1IBA 01/2018 - 02/2006
6	Atrial Natriuretic Factor (ANF)IBA 03/2016 - 02/2004
6	CD40 Ligand (CD40L)IBA 02/2015 - 01/2008
6	Triglycerides (Triacylglycerol)IBA 12/2014 - 02/2006
5	Indicators and Reagents (Reagents)IBA 12/2024 - 02/2008
5	CalciumIBA 12/2023 - 02/2004
5	LeptinIBA 10/2022 - 04/2009
5	Warfarin (Coumadin)FDA LinkGeneric 01/2022 - 08/2003
5	MicroRNAs (MicroRNA)IBA 01/2020 - 04/2014
5	Vasodilator Agents (Vasodilators)IBA 05/2017 - 12/2004
5	Lipoproteins (Lipoprotein)IBA 02/2016 - 11/2005
5	Oxyhemoglobins (Oxyhemoglobin)IBA 01/2016 - 10/2006
5	1-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA 02/2015 - 06/2009
4	Troponin IIBA 05/2024 - 01/2014
4	AnticoagulantsIBA 01/2023 - 08/2015
4	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2019 - 10/2004
4	AdiponectinIBA 02/2016 - 03/2009
4	IsoprostanesIBA 02/2016 - 02/2008
4	Peroxidase (Myeloperoxidase)IBA 02/2015 - 03/2011
4	Tissue Inhibitor of Metalloproteinase-1IBA 12/2010 - 09/2004
4	Peptides (Polypeptides)IBA 08/2010 - 02/2004
4	N-terminal proatrial natriuretic peptideIBA 01/2010 - 02/2004
4	SodiumIBA 03/2008 - 02/2004
3	Matrix Metalloproteinases (MMPs)IBA 05/2024 - 11/2008
3	Fatty Acids (Saturated Fatty Acids)IBA 01/2023 - 04/2010
3	Blood Glucose (Blood Sugar)IBA 01/2022 - 03/2003
3	Vitamin K FDA Link 01/2020 - 02/2008
3	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 01/2018 - 03/2011
3	P-2 (P 2)IBA 01/2018 - 03/2009
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2016 - 05/2009
3	N,N-dimethylarginine (asymmetric dimethylarginine)IBA 01/2016 - 03/2009
3	HDL LipoproteinsIBA 01/2016 - 01/2005
3	Arginine (L-Arginine)FDA Link 01/2016 - 03/2009
3	LigandsIBA 03/2014 - 11/2008

Therapy/Procedure

20	Therapeutics 04/2024 - 02/2006
7	Catheter Ablation 11/2020 - 02/2010
6	Hormone Replacement Therapy (Therapy, Hormone Replacement) 01/2016 - 05/2005
4	Precision Medicine 05/2024 - 06/2010
4	Secondary Prevention 01/2021 - 02/2009